untitled

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

深圳市海王英特龍生物技術股份有限公司

SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED*

(a joint stock limited company incorporated in the People's Republic of China)

(Stock Code: 8329) CHANGE OF JOINT COMPANY SECRETARY, FINANCIAL CONTROLLER AND AUTHUORISED REPRESENTATIVE

The Board announces that with effect from7 April 2016:

  1. Mr. Huang Jian Bo has resigned as the Joint Company Secretary, the Financial Controller and the Authorised Representative; and

  2. Ms. Mu Ling Xia has been appointed in place of Mr. Huang as the Joint Company Secretary, the Financial Controller and the Authorised Representative.

The board (the "Board") of directors (the "Directors") of Shenzhen Neptunus Interlong Bio-technique Company Limited (the "Company", together with its subsidiaries, the "Group") hereby announces that with effect from 7 April 2016, Mr. Huang Jian Bo ("Mr. Huang") has resigned as the joint company secretary of the Company (the "Joint Company Secretary"), the financial controller of the Company (the "Financial Controller") and the authorised representative of the Company (the "Authorised Representative") due to his work arrangement.

Mr. Huang has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the shareholders of the Company. The Board is also not aware of any such matters in relation to the resignation of Mr. Huang that needs to be brought to the attention of the Stock Exchange and the shareholders of the Company.

The Board would like to express its gratitude to Mr. Huang for his valuable contributions to the Company during his tenure of office with the Company.

The Board is also pleased to announce that Ms. Mu Ling Xia ("Ms. Mu") has been appointed in place of Mr. Huang as the Joint Company Secretary, the Financial Controller and the Authorised Representative with effect from 7 April 2016.

Set out below is the biography of Ms. Mu:-

Ms. Mu Ling Xia(慕凌霞), aged 46, graduated from Xi'an Jiaotong University majoring in applied economics and obtained a master degree in economics. Ms. Mu is a qualified board secretary of listed companies as recognised by the Shenzhen Stock Exchange and has participated in ECDP talk held by the Hong Kong Institute of Chartered Secretaries in 2013 and an advance seminar course on Hong Kong and China enterprise regulations in 2015. Ms. Mu possesses nearly 18 years of experience in listing company governance, capital operations, information disclosure and investor relations management. She was the board secretary of Shenzhen Overglobe Development Company Limited*(深圳市中僑發展股份有限公

司)("Overglobe Development") (the shares of which were listed on the Shenzhen Stock Exchange), the

director of the board office and the securities affairs representative authorised by the board of directors of Shenzhen Neptunus Bio-engineering Company Limited*(深圳市海王生物工程股份有限公司) ("Neptunus Bio-engineering") (the shares of which are listed on the Shenzhen Stock Exchange), the controlling shareholder of the Company.

Ms. Mu is also qualified as a professional accountant in China and has securities practice qualification. She was also appointed by Neptunus Bio-engineering to participate in an advance seminar course of finance and possesses professional financial knowledge and financial analytical capability. Ms. Mu has relevant working experience in finance and accounting as well as extensive experience in investment and financing. She participated in the establishment preparation and related finance and accounting work for Overglobe Development's subsidiary and also participated in investment and acquisition of various projects of Neptunus Bio-engineering.

The Board would like to take this opportunity to express welcome for Ms. Mu's appointment.

By the order of the Board

Shenzhen Neptunus Interlong Bio-technique Company Limited* Zhang Feng

Chairman

Shenzhen, the PRC, 7 April 2016

As at the date of this announcement, the executive Directors are Mr. Zhang Feng, Mr. Xu Yan He and Mr. Zhao Wen Liang; the non-executive Directors are Mr. Liu Zhan Jun, Ms. Yu Lin and Mr. Song Ting Jiu; and the independent non-executive Directors are Mr. Yick Wing Fat, Simon, Mr. Poon Ka Yeung and Mr. Zhang Jian Zhou.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of the Stock Exchange for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief: (i) the information contained in this announcement is accurate and complete in all material aspects and not misleading or deceptive; and (ii) there are no other matters the omission of which would make any statement in this announcement or this announcement misleading.

This announcement will remain on the" Latest Company Announcements" page of the GEM website at http://www.hkgem.com for at least 7 days from its date of publication and on the website of the Company at www.interlong.com.

* For identification purposes only

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. issued this content on 07 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 26 April 2016 06:30:41 UTC

Original Document: http://www.interlong.com/Uploads/News/571f06d213ab9.pdf